Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase 2 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 106Leukemia 98Lymphoma 79Burkitt Lymphoma 52Leukemia, Myeloid, Acute 51Myelodysplastic Syndromes 41Lymphoma, Non-Hodgkin 41Lymphoma, Large B-Cell, Diffuse 35Lymphoma, Mantle-Cell 33Leukemia, Lymphocytic, Chronic, B-Cell 32Leukemia, Myeloid, Accelerated Phase 30Hodgkin Disease 29Lymphoma, Follicular 28Blast Crisis 27Graft vs Host Disease 26Congenital Abnormalities 26Myeloproliferative Disorders 25Leukemia, Myeloid, Chronic-Phase 25Multiple Myeloma 24Breast Neoplasms 23Lymphoma, B-Cell, Marginal Zone 22Leukemia, Myelomonocytic, Chronic 22Lymphoma, Large-Cell, Immunoblastic 21Primary Myelofibrosis 16Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 16Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 16Recurrence 15Neoplasms, Plasma Cell 15Dendritic Cell Sarcoma, Interdigitating 15Anemia, Refractory, with Excess of Blasts 15

Interventions

pegaspargase 1nelarabine 1mogamulizumab 1forodesine 1Vincristine 1Panobinostat 1Mitoxantrone 1Methotrexate 1Mercaptopurine 1Etoposide 1Dexamethasone 1Cytarabine 1Cyclophosphamide 1Clofarabine 1Calcium Dobesilate 1Bortezomib 1A-dmDT390-bisFv(UCHT1) protein 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, T-Cell × Methotrexate × Clear all
NCT02518750 2019-04-03

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma

St. Jude Children's Research Hospital

Phase 2 Terminated
3 enrolled 6 charts
LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡